Chemours (CC) PT Lowered to $46 at BMO Capital

September 22, 2022 12:32 PM EDT Send to a Friend
BMO Capital analyst John McNulty lowered the price target on Chemours (NYSE: CC) to $46.00 (from $55.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login